hims & hers glp-1 Just Launched an Ozempic Dupe Hims & Hers Expands GLP-1

Conditions and situations we treat in medical weight loss Medical weight loss work overlaps significantly with chronic disease management

*Contraindications weight loss injections include a personal or family history of medullary thyroid cancer, allergy to GLP-1 and weight loss injections, Type 1 Diabetes or history of Diabetic Ketoacidosis, personal or family history of Multiple Endocrine Neoplasia, personal history of Pancreatitis, renal impairment or kidney disease, gallbladder disease, or concurrent use of anti-diabetic medications or insulin

GLP-1 receptor agonists are useful, injectable drugs for the treatment of T2D as they improve glycemic control and atherosclerosis-related parameters [17-26]

NICE NG28 GLP-1 RA or tirzepatide should be added as further therapy for T2D with obesity after at least 3 months of initial therapy if glycemic targets are not met